7Baggers
 Aldeyra expands RASP platform  TipRanks Thu, 13 Nov 2025 20:12:24 GMT
 published on: 2025-11-13 10:43:17  newser.com Thu, 13 Nov 2025 16:43:17 GMT
 aldeyra expands rasp platform to include neuroinflammatory diseases by investing.com  Investing.com Australia Thu, 13 Nov 2025 12:54:17 GMT
 Aldeyra Therapeutics Expands RASP Platform in 2025 Webcast  TipRanks Thu, 13 Nov 2025 12:36:06 GMT
 Aldeyra Therapeutics announces expansion of rasp platform  MarketScreener Thu, 13 Nov 2025 12:31:40 GMT
 key fda verdict looms for aldeyra’s lead drug candidate  AD HOC NEWS Thu, 13 Nov 2025 12:04:04 GMT
 (aldx) movement as an input in quant signal sets  news.stocktradersdaily.com Wed, 12 Nov 2025 19:04:02 GMT
 published on: 2025-11-10 01:01:45  newser.com Mon, 10 Nov 2025 07:01:45 GMT
 aldeyra therapeutics shares plunge following quarterly report  AD HOC NEWS Thu, 06 Nov 2025 10:14:04 GMT
 published on: 2025-11-03 21:46:12  newser.com Tue, 04 Nov 2025 03:46:12 GMT

Aldeyra Therapeutics, Inc
(NASDAQ:ALDX) 

ALDX stock logo

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, an ophthalmic solution, which is in Phase III clinical trial for the treatment of dry eye diseases and alle...

Founded: 2004
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends